FDA Approval of DS-8201
- Thread starter anonymous
- Start date
-
- Tags
- None
Well guess what, this is just the first shot on goal. Many other indications to come. This one drug will make billions. Add in the rest of the emerging pipeline and DS becomes a top oncology company.
At least the people selling it are all 7 footers in a company full of 5 foot, not fit for ONC positions, lucky Just to receive a paycheck INJ reps, right KW? 
Can’t wait to keep doing one inservice a day and 8 promo drops until I find a gig worthy of my efforts. And save the company line garbage. Upper level doesn’t give a damn about us, why should we give a damn about them?
Flying under the radar (and to Iceland) in 2020
Can’t wait to keep doing one inservice a day and 8 promo drops until I find a gig worthy of my efforts. And save the company line garbage. Upper level doesn’t give a damn about us, why should we give a damn about them?
Flying under the radar (and to Iceland) in 2020
gosh KW nothing better to do over the weekend?
At least the people selling it are all 7 footers in a company full of 5 foot, not fit for ONC positions, lucky Just to receive a paycheck INJ reps, right KW?
Can’t wait to keep doing one inservice a day and 8 promo drops until I find a gig worthy of my efforts. And save the company line garbage. Upper level doesn’t give a damn about us, why should we give a damn about them?
Flying under the radar (and to Iceland) in 2020
I drop off coffee and bagels around 930, after the gym. grab a long shower and the a quick in service with food and free lunch for me. Sometimes I’ll do another food drop if I’m still hungry, others I just call it a day. easiest beans I’ve ever made
PLEASE QUIT - IF YOUR NOT OPTIMISITC ANOUT THIS DRUG- YOUR BOTH STUPID AND PATHETIC
Honest question and no smart ass responses . How many patients are in reality out here for 8201? I’m not on that team but from what’s being said and I have heard from actual Onc docs it’s looking like very few . So does that mean they may lay-off oncology reps or iron reps , bc it’s captain obvious that there are way too reps for the sales that will be booked in 2020 unless there is something I don’t know about???
Why? Give up a fat check? Good healthcare and benefits? I work like 8 hours a week no way I’m quitting. Optimistic? Ask KW to tell you about his sales leadership experience and launch experience. Guy never worked in ONC and the stuff he says shows me how clueless we are. 8201 - ‘the next DSI failure’
It’s very small, just go to CDC website and NCCN and you can see all the numbers so you can form your own opinion, we’re talking fewer than 3k in the US. Plus 8201 showed a lung safety signal that is worrisome. even if we got half those patients, which ain’t happening your talking at best a 100M drug so yes we will eventually lose our jobs
It’s pretty clear this person was fired from DSI. Should be fairly easy to determine who this loser is. This person is way underestimating this drug and the patient population that will be served by it.
Spot on. If one did their homework on prevalence and safety profile, they might have had 2nd thoughts. Oh but many needed jobs because they were displaced or soon to be displaced. Remember this post, next up - wait for all the drama over IC payout.
Go look up the numbers, maybe you think the CDC is making them up? I didn’t get fired you just don’t like reality so you sling names and accusations. I mean I get it, you’re not bright so you lash out. Advances in BC over past decade have dramatically improved survival and decreased 3rd line agents. You clearly don’t know JACK. Good try Keith
No need to guess, easy to find these numbers. Only 5% of BC DX are metastatic, so that’s maybe 12K per year, about 150K women have metastatic BC and only 1 in 5 are HER2 positive - maybe less - but that’s 30,000 at most. 8201 wont be used first or second line in those patients leaving maybe 5K. Just go do some homework. Talk to Bob or Mike about our inability to make enough supply for that small number. Facts are facts, sorry the truth is so hard for you.
Shaky safety profile, multiple line failures, no ONC experience. First year sales likely 50-75M - at best.
Exactly, he was let go and now he’s attempting to “get even”. Sorry dude that you couldn’t cut it.
sorry to burst your bubble, we all make coffee runs, all are lunch jockeys and responding to your own posts is like public masturbation. you don’t like my work approach? Awwww
Wtf! That’s no money . What is going on ? Why did they ramp up that drug with a headcount more in line with a community oncology type drug ? Something is not adding up ... is something else coming out soon for them to sell ?
Daiichi-Sankyo folks, just ignore these negative posters. And don’t comment on what else is coming. Let these chuckleheads find out. Enhertu will be a special, transformational drug.